インディアナ州における脂肪肝の臨床試験
インディアナ州内の拠点で、脂肪肝に関する9件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト（英語）
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Indiana University School of Medicine, Indianapolis
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Indiana University Health University Hospital, Indianapolis
- Gastroenterology Health Partners, New Albany
- Deaconess Clinic- Gateway, Newburgh
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Hammond
- Akero Clinical Study Site, Indianapolis
- Akero Clinical Study Site, South Bend
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Digestive Research Alliance of Michiana, South Bend
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/09更新 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/03更新 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Indianapolis
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/08/03更新 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Indiana University, Indianapolis
被験者募集中第4相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/07/31更新 · NCT06374875Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Indiana University Health, Indianapolis
被験者募集中
18歳〜75歳 · 全性別 · 2026/05/19更新 · NCT04054310ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。